Ensign rises 8.6% after raised outlook on third-quarter results

What happened

Ensign (ENSG) rose 8.6% on October 28, 2026, after reporting third-quarter revenue and earnings growth and raising its 2026 earnings outlook because of the results. The stock closed at $184.11, with trading volume 2.8 times its 20-day average. Management cited higher occupancy, a greater skilled-nursing mix, acquisitions and entry into Florida and said it was seeing a pipeline of acquisition opportunities.

How big was the move

The session outperformed the Healthcare sector median by 7.0 percentage points while the S&P 500 rose 0.3%. The stock’s one-day change was 5.0 times a typical daily move for this stock, and it opened 5.2% above the previous close. Market value was $10.23 billion at the close, suggesting investors treated the earnings as a meaningful catalyst. The company’s beta of 0.14 indicates the stock tends to move less than the market.

The technical picture

Technically, the stock was 5.7% above its 20-day moving average and 5.4% above its 50-day moving average, while the 50-day average remained below the 200-day average, a sign of a weak longer-term trend; the stock was 1.4% above its 200-day moving average. The shares were 15.5% below the 52-week high and the 14-day Relative Strength Index read 60, inside a neutral range. Over one month the stock rose 4.9% and over three months it rose 3.0%, while over one year it fell 1.3%, lagging the S&P 500 by 13.9 percentage points. Volatility was 27% annualized over 60 days, higher than 59% of its own readings over five years, indicating relatively elevated recent price swings.

Fundamentals and valuation

For the four quarters through September 30, 2026, revenue was $5.67 billion, which grew 17.5% from a year earlier, and diluted earnings per share were $6.72, which rose 20.2% from a year earlier. Operating margin improved to 9.0% from 8.3% a year earlier even as gross margin narrowed to 14.7% from 15.7%. Free-cash-flow margin was 9.0% and return on invested capital was 7.1%. Net debt stood at 2.9 times EBITDA and share count increased by 0.6% over one year.

On valuation, the stock traded at 27.4 times trailing earnings and 23.6 times expected earnings, with a free-cash-flow yield of 5.0%. Its price-to-trailing-earnings reading was higher than 57% of its own readings over the past five years, with a five-year median of 25.0 times earnings. Those metrics suggest investors are willing to pay a premium for the company’s growth and stability, even as the multiple sits above the five-year median.

PromtFinance scores ranked the company highly on Stability at 90 (Exceptional), with Value 82 (Strong), Growth 72 (Positive) and Quality 70 (Positive). Momentum read 51 (Neutral) and Revisions read 63 (Neutral), reflecting mixed signals from recent analyst activity and price action.

Earnings and analyst expectations

Ensign’s last report on October 27, 2026, showed earnings per share of $2.03 against $1.97 expected, 3.0% above estimates, extending a streak of 15 consecutive quarters beating estimates. Analysts’ consensus price target was $215.00, 16.8% above the closing price, based on 13 analysts with a consensus rating of Buy and 69% of ratings at Buy or Strong Buy. The company’s average surprise over the last four reports was 3.8% above estimates. The next report was scheduled for November 2, 2026.

The earnings beat and raised guidance offered a clear near-term catalyst, but the stock’s valuation and the weak longer-term technical trend temper an otherwise positive reading for some investors. The company’s improvement in operating margin and solid free-cash-flow margin support the case that earnings gains are translating into cash generation.

What to watch

• November 2, 2026: next earnings report date.
• The company’s updated 2026 earnings guidance following the October 27, 2026, report and the pace of acquisitions cited in the announcement.
• Any developments in the class action litigation timeline, including the December 7, 2026, lead plaintiff/application deadline noted in legal notices.
• Trading volume relative to the 20-day average in the sessions after the earnings release to gauge investor follow-through.